153 related articles for article (PubMed ID: 25128515)
41. Evaluation of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with type 2 diabetes mellitus.
Isik S; Ozcan HN; Ozuguz U; Tutuncu YA; Berker D; Alimli AG; Akbaba G; Karademir MA; Guler S
J Clin Endocrinol Metab; 2012 Jan; 97(1):261-9. PubMed ID: 22031524
[TBL] [Abstract][Full Text] [Related]
42. There is a Positive Correlation Between Socioeconomic Status and Ovarian Reserve in Women of Reproductive Age.
Barut MU; Agacayak E; Bozkurt M; Aksu T; Gul T
Med Sci Monit; 2016 Nov; 22():4386-4392. PubMed ID: 27847382
[TBL] [Abstract][Full Text] [Related]
43. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
44. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.
Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B
Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580
[TBL] [Abstract][Full Text] [Related]
45. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
46. Long-term effect of systemic isotretinoin on female fertility.
Cinar SL; Kartal D; Aksoy H; Cinar E; Aydin T; Öz L; İmamoğlu H; Ferahbas A; Borlu M
Cutan Ocul Toxicol; 2017 Jun; 36(2):132-134. PubMed ID: 27292185
[TBL] [Abstract][Full Text] [Related]
47. Adrenal steroidogenesis and ovarian reserve in adult childhood-onset systemic lupus erytematosus patients.
Lourenço DMR; Araújo DB; Aikawa NE; Yamakami LYS; Borba EF; Maciel GAR; Soares-Junior JM; Baracat EC; Pereira RMR; Bonfa E; Silva CA
Clin Rheumatol; 2021 Sep; 40(9):3651-3658. PubMed ID: 33712890
[TBL] [Abstract][Full Text] [Related]
48. Menstrual and hormonal alterations in juvenile dermatomyositis.
Aikawa NE; Sallum AM; Leal MM; Bonfá E; Pereira RM; Silva CA
Clin Exp Rheumatol; 2010; 28(4):571-5. PubMed ID: 20598224
[TBL] [Abstract][Full Text] [Related]
49. Comparative analysis of ovarian reserve in women with obesity in reproductive period.
Grigoryan OR; Mikheev RK; Andreeva EN; Dedov II
Ter Arkh; 2018 Nov; 90(10):30-34. PubMed ID: 30701792
[TBL] [Abstract][Full Text] [Related]
50. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels.
Henes M; Froeschlin J; Taran FA; Brucker S; Rall KK; Xenitidis T; Igney-Oertel A; Lawrenz B; Henes JC
Rheumatology (Oxford); 2015 Sep; 54(9):1709-12. PubMed ID: 25957439
[TBL] [Abstract][Full Text] [Related]
51. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
52. Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.
Fabbri R; Macciocca M; Melotti C; Pasquinelli G; Vicenti R; Bacchi Reggiani ML; Terribile D; Venturoli S
Future Oncol; 2014 Jun; 10(8):1343-51. PubMed ID: 25052745
[TBL] [Abstract][Full Text] [Related]
53. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values.
Polyzos NP; Sakkas E; Vaiarelli A; Poppe K; Camus M; Tournaye H
Hum Reprod; 2015 Jul; 30(7):1690-6. PubMed ID: 25948573
[TBL] [Abstract][Full Text] [Related]
54. Ovarian reserve in an Egyptian cohort with end-stage kidney disease on hemodialysis and after successful kidney transplantation: a prospective study.
Fayed A; Soliman A; Naguib M; Soliman M; Salaheldin M
Int Urol Nephrol; 2019 Apr; 51(4):737-743. PubMed ID: 30737642
[TBL] [Abstract][Full Text] [Related]
55. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
[TBL] [Abstract][Full Text] [Related]
56. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
57. Determinants of arterial stiffness in female patients with Takayasu arteritis.
Salles Rosa Neto N; Levy-Neto M; Tolezani EC; Bonfá E; Bortolotto LA; Pereira RM
J Rheumatol; 2014 Jul; 41(7):1374-8. PubMed ID: 24882839
[TBL] [Abstract][Full Text] [Related]
58. Does obesity compromise ovarian reserve markers? A clinician's perspective.
Malhotra N; Bahadur A; Singh N; Kalaivani M; Mittal S
Arch Gynecol Obstet; 2013 Jan; 287(1):161-6. PubMed ID: 22930149
[TBL] [Abstract][Full Text] [Related]
59. Ovarian reserve in patients with multiple sclerosis: A systematic review and meta-analysis.
Carbone L; Di Girolamo R; Conforti A; Iorio GG; Simeon V; Landi D; Marfia GA; Lanzillo R; Alviggi C
Int J Gynaecol Obstet; 2023 Oct; 163(1):11-22. PubMed ID: 37017322
[TBL] [Abstract][Full Text] [Related]
60. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.
Ma W; Zhan Z; Liang X; Chen J; Huang X; Liao C
J Womens Health (Larchmt); 2013 Dec; 22(12):1023-7. PubMed ID: 24283710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
